Jim Rosack Psychiatric News The U.S. Food and Drug Administration (FDA) posted the final language for its new, required labeling of antidepressants last month, including
Antidepressants carry risks
LJWorld.com By Dr. Joseph Glenmullen I am writing in response to the Jan. 11 article, “Double take: Medication just one part of treating depressed teenagers,”
F.D.A. Official Admits ‘Lapses’ on Vioxx
By GARDINER HARRIS The New York Times WASHINGTON, March 1 – After the Food and Drug Administration insisted for months that it did nothing wrong
Warning Didn’t Slow Approval of MS Drug
By Ricardo Alonso-Zaldivar and Denise Gellene The Los Angeles Times WASHINGTON — A multiple sclerosis drug pulled off the market after a patient died was
Are the SSRIs and Atypical Antidepressants Safe and Effective for Children and Adolescents?
Tim Kendall Steve Pilling Craig J. Whittington, PhD Curr Opin Psychiatry 18(1):21-25, 2005. Abstract and Introduction Purpose of Review: This article summarizes recent developments in
